Peking University, November 15, 2023: During the 6th China International Import Expo (CIIE) held in Shanghai recently, the PKU-MSD Joint Lab on Infectious Disease Prevention and Control Technology was officially launched. (Editor's note: Merck Sharp and Dohme (MSD) is a multi-national pharmaceutical company.)

Xiao Yuan, vice president of Peking University Health Science Center (PKUHSC), and Anna Van Acker, senior vice president of MSD Global and President of MSD China, delivered speeches on behalf of PKUHSC and MSD respectively. 

Both sides stressed that they would take the Joint Lab as the starting point of their new journey, relying on the innovative research and development advantages of MSD and the profound scientific and academic resources of Peking University, to build an innovation ecosystem that closely integrates industry, academia, and research. 

The two sides also agreed to explore new paths to improve the level of medical technology innovation and accelerate the transformation of technological achievements to inject new momentum into the building of China's public health system and achieve the grand goal of building a healthy China.
 

For many years, Peking University has been actively promoting joint innovation with domestic and foreign enterprises, exploring and practicing collaboration models of building joint research and development platforms between universities and enterprises. To this end, the PKU-MSD Joint Lab on Infectious Disease Prevention and Control Technology would serve to reinforce the above-mentioned collaboration paradigm.

This article was featured in the special coverage of PKU's Global Engagement Year.



Written by: Wu Zhaoxia
Edited by: Dennis Meng
Source: School of Public Health